tiprankstipranks
Inozyme Pharma (INZY)
NASDAQ:INZY
US Market
Holding INZY?
Track your performance easily

Inozyme Pharma (INZY) Technical Analysis

712 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Inozyme Pharma’s (INZY) Moving Averages Convergence Divergence (MACD) indicator is -0.18, suggesting Inozyme Pharma is a Sell.
Inozyme Pharma’s (INZY) 20-Day exponential moving average is 2.96, while Inozyme Pharma’s (INZY) share price is $2.99, making it a Buy.
Inozyme Pharma’s (INZY) 50-Day exponential moving average is 3.52, while Inozyme Pharma’s (INZY) share price is $2.99, making it a Sell.

Inozyme Pharma (INZY) Pivot Points

Dec 22, 2024, 03:10 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.48
2.56
2.69
2.77
2.90
2.98
3.11
Fibonacci
2.56
2.64
2.69
2.77
2.85
2.90
2.98
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Inozyme Pharma (INZY) Moving Averages

Dec 22, 2024, 03:10 PM
Period
Simple
Exponential
MA5
2.90Buy
2.90Buy
MA10
2.92Buy
2.89Buy
MA20
2.79Buy
2.96Buy
MA50
3.70Sell
3.52Sell
MA100
4.43Sell
4.08Sell
MA200
4.78Sell
4.53Sell
Inozyme Pharma’s (INZY) 10-Day exponential moving average is 2.89, while Inozyme Pharma’s (INZY) share price is $2.99, making it a Buy.
Inozyme Pharma’s (INZY) 100-Day exponential moving average is 4.08, while Inozyme Pharma’s (INZY) share price is $2.99, making it a Sell.
Inozyme Pharma’s (INZY) stock price is $2.99 and Inozyme Pharma’s (INZY) 50-day simple moving average is 3.70, creating a Sell signal.
Inozyme Pharma’s (INZY) stock price is $2.99 and Inozyme Pharma’s (INZY) 100-day simple moving average is 4.43, creating a Sell signal.
Inozyme Pharma’s (INZY) stock price is $2.99 and Inozyme Pharma’s (INZY) 200-day simple moving average is 4.78, creating a Sell signal.

Inozyme Pharma (INZY) Technical Indicators

Dec 22, 2024, 03:10 PM
Name
Value
Implied Action
RSI (14)
46.60
Neutral
STOCH (9,6)
34.33
Neutral
STOCHRSI (14)
43.57
Neutral
MACD (12,26)
-0.18
Sell
ADX (14)
29.40
Neutral
Williams %R
-43.72
Buy
CCI (14)
62.32
Neutral
ATR (14)
0.27
-
Ultimate Oscillator
42.45
Neutral
ROC
7.17
Buy
Inozyme Pharma’s (INZY) Relative Strength Index (RSI) is 46.60, creating a Neutral signal.
Inozyme Pharma’s (INZY) Trend Strength Indicator (ADX) is 29.40, creating a Neutral signal.
Inozyme Pharma’s (INZY) Commodity Channel Index (CCI) is 62.32, creating a Neutral signal.
Inozyme Pharma’s (INZY) Price Rate of Change (ROC) is 7.17, creating a Buy signal.

FAQ

Is INZY a Buy, Hold, or Sell?
Based on INZY’s technical indicators, INZY is a Hold.
    What is INZY’s RSI (14)?
    INZY’s RSI (14) is 46.60, which suggests INZY is a Neutral.
      What is INZY’s MACD?
      INZY’s MACD is -0.18, which suggests INZY is a Sell.
        What is INZY’s 5-day moving average?
        INZY’s 5-day moving average is 2.90, which suggests INZY is a Buy.
          What is INZY’s 20-day moving average?
          INZY 20-day moving average is 2.79, which suggests INZY is a Buy.
            What is INZY’s 50-day moving average?
            INZY’s 50-day moving average is 3.70, which suggests INZY is a Sell.
              What is INZY’s 200-day moving average?
              INZY’s 200-day moving average is 4.78, which suggests INZY is a Sell.
                What is INZY’s Williams % R (14)?
                INZY’s Williams % R (14) is -43.72, which suggests INZY is a Buy.
                  What is INZY’s CCI (14)?
                  INZY’s CCI (14) is 62.32, which suggests INZY is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis